LSC Webinars

  1. From Platform To Patient: Streamlining Gene Therapy Development 12/5/2024

    Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.

  2. Removing The Headache: Outsourced Stability Storage And Testing Solutions 12/4/2024

    Should you manage certain operations internally or partner with a trusted external provider? Watch experts discuss the benefits of outsourcing stability, storage, and testing.

  3. Charting A Successful CMC Journey For Your ADC Drug Product 12/3/2024

    These real-world case studies highlight best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in the clinical or commercial phase.

  4. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

  5. How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms 11/25/2024

    Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.

  6. Manufacturing Strategies And Facility Design For Patient-Centric Delivery 11/21/2024

    Review how to select the optimal manufacturing strategy and leverage technologies for efficient and scalable production of therapeutic proteins. De-risk the supply chain, accelerate time to market, and reduce costs.

  7. Using An Adherent Platform To Scale-Up An Upstream Viral Vector Process 11/20/2024

    Gain insight into a helper-dependent adenovirus (HDAd) process that covers everything from bench-scale and optimization to tech transfer.

  8. Vector Technology For Improved Expression Control Of Biotherapeutic Proteins 11/19/2024

    Discover enhanced vector technology developed to enable better control of expression in cells, enhance titers, and improve expression stability for a range of biotherapeutic formats.

  9. Contamination Control Strategy With QRM Principles 11/19/2024

    Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS.

  10. Innovative Technology For Developing, Scaling Peptide-Based Therapeutics 11/18/2024

    Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.